Prelude Capital Management’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,722
| Closed | -$28.6K | – | 1460 |
|
|
2024
Q1 | $28.6K | Buy |
+1,722
| New | +$28.6K | ﹤0.01% | 1158 |
|
|
2023
Q4 | – | Sell |
-1,480
| Closed | -$113K | – | 1297 |
|
|
2023
Q3 | $113K | Hold |
1,480
| – | – | 0.01% | 837 |
|
|
2023
Q2 | $97.1K | Hold |
1,480
| – | – | 0.01% | 819 |
|
|
2023
Q1 | $88.5K | Buy |
+1,480
| New | +$88.5K | 0.01% | 865 |
|